COVID-19 is here to stay, and for some, that means symptoms last months, even years after developing the little-understood Long COVID — but a team at the Ohio State University has received millions to ...
In a recent study posted to the bioRxiv* preprint server, researchers evaluated the efficacy of small molecule drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback